Literature DB >> 8137479

Hepatic resections for primary liver cancer.

S T Kim1, K P Kim.   

Abstract

The medical records of 399 patients who underwent hepatic resection between January 1981 and December 1990 were reviewed. Information regarding the results of the hepatic resection in terms of the operative indication, operative procedure, operative morbidity, and mortality was abstracted. As of the end of 1990, a total of 402 hepatic resections had been completed, including those of 319 primary malignancies, 4 secondary malignancies, 2 gallbladder carcinomas, 42 cases of intrahepatic cholelithiasis, and 35 benign masses. Major hepatic resections were performed on 117 patients (29%), of whom 60 (51%) had histologically proven liver cirrhosis. Minor hepatic resections were performed on the remaining 285 patients (71%). Sepsis was the most frequent complication, which manifested primarily as wound infection (71 cases) or intra-abdominal infection (25 cases). Nonfatal hepatic failure occurred in nine patients with cirrhosis and one patient without cirrhosis. There were 38 operative deaths among the 402 hepatic resections, for an overall operative mortality of 9.4%; 25 of those deaths were due to hepatic failure after the operation, accounting for 66% of the total operative mortality. There was an increasing frequency of hepatic resection during the last 5 years. The indication for resection due to hepatocellular carcinoma increased from 87 to 195 cases. The cumulative data show a decrease in the incidence of complications and the operative mortality rate. In the most recent period, nonlethal postoperative complications occurred in 135 of 286 patients (47%). The overall 1-, 3-, and 5-year survival rates for 172 patients, excluding cases of operative mortality, palliative resection, and re-resection, were 71.0%, 39.8%, and 28.3%, respectively.

Entities:  

Mesh:

Year:  1994        PMID: 8137479     DOI: 10.1007/bf00686662

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  15 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

Review 2.  Liver resection. Preoperative and postoperative care.

Authors:  M D Stone; P N Benotti
Journal:  Surg Clin North Am       Date:  1989-04       Impact factor: 2.741

3.  Segmental and subsegmental resections of the cirrhotic liver under hepatic inflow and outflow occlusion.

Authors:  N Nagasue; H Yukaya; Y Ogawa; S Hirose; M Okita
Journal:  Br J Surg       Date:  1985-07       Impact factor: 6.939

4.  One hundred hepatic resections. Indications and operative results.

Authors:  T Nagao; S Inoue; T Mizuta; H Saito; N Kawano; Y Morioka
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

5.  Major liver resection: perioperative course and management.

Authors:  H Ekberg; K G Tranberg; R Andersson; B Jeppsson; S Bengmark
Journal:  Surgery       Date:  1986-07       Impact factor: 3.982

6.  Intraductal variant of peripheral cholangiocarcinoma of the liver with Clonorchis sinensis infection.

Authors:  Y I Kim; E S Yu; S T Kim
Journal:  Cancer       Date:  1989-04-15       Impact factor: 6.860

7.  Hepatocellular carcinoma. Changing concepts in diagnosis and management.

Authors:  R C Lim; F S Bongard
Journal:  Arch Surg       Date:  1984-06

8.  Predicting septic related mortality of the individual surgical patient based on admission host-defence measurements.

Authors:  N V Christou
Journal:  Can J Surg       Date:  1986-11       Impact factor: 2.089

9.  Experience with 150 liver resections.

Authors:  S Iwatsuki; B W Shaw; T E Starzl
Journal:  Ann Surg       Date:  1983-03       Impact factor: 12.969

10.  Limited hepatic resection effective for selected cirrhotic patients with primary liver cancer.

Authors:  T Kanematsu; K Takenaka; T Matsumata; T Furuta; K Sugimachi; K Inokuchi
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

View more
  4 in total

1.  Basolateral potassium (IKCa) channel inhibition prevents increased colonic permeability induced by chemical hypoxia.

Authors:  A Loganathan; J E Linley; I Rajput; M Hunter; J P A Lodge; G I Sandle
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-21       Impact factor: 4.052

2.  Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.

Authors:  S T Fan; C M Lo; C L Liu; C M Lam; W K Yuen; C Yeung; J Wong
Journal:  Ann Surg       Date:  1999-03       Impact factor: 12.969

Review 3.  Practical considerations in the treatment of hepatocellular carcinoma.

Authors:  M Colleoni; R A Audisio; F De Braud; N Fazio; G Martinelli; A Goldhirsch
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

4.  Role of liver transplantation in the treatment of unresectable liver cancer.

Authors:  R Pichlmayr; A Weimann; K J Oldhafer; H J Schlitt; J Klempnauer; A Bornscheuer; A Chavan; E Schmoll; H Lang; G Tusch
Journal:  World J Surg       Date:  1995 Nov-Dec       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.